PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Botnar Research Centre, University of Oxford, Oxford, UK. peter.taylor@kennedy.ox.ac.uk.\', \'Eli Lilly and Company, Indianapolis, IN, USA.\', \'Oregon Health & Science University, Portland, OR, USA.\', \'Baylor University Medical Center, Dallas, TX, USA.\', \'Baylor Scott & White Research Institute, Dallas, TX, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41577-021-00542-x
?:doi
?:hasPublicationType
?:journal
  • Nature reviews. Immunology
is ?:pmid of
?:pmid
?:pmid
  • 33875867
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Neutralizing monoclonal antibodies for treatment of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33875867>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33875867>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all